News
@Release


Capital increase through third-party allocation (November 6, 2004)
Increased capital to 585 million yen through allocation of new shares to a third party in November 2004.
Capital increase through third-party allocation (August 1, 2004)
Increased capital to 510 million yen through allocation of new shares to a third party in August 2004.
2004 Kagawa innovative technology, research, and development grant project (June 7, 2004)
Our development of neutrophil activity modulators on the basis of galectin was selected as part of the 2004 Kagawa innovative technology, research, and development grant project.
Capital increase through third-party allocation (May 2, 2004)
Increased capital to 430 million yen through allocation of new shares to a third party in May 2004. @
Capital increase through third-party allocation(December 26,2005)
Increased capital to 877.5 million yen through allocation of new shares to a third party in December 2005.@
@
@